Возможности диетического контроля гиперфосфатемии при ХБП (Обзор литературы)
Аннотация
В обзоре литературы приводятся данные о возможностях диетической коррекции гиперфосфатемии у больных с ХБП на заместительной почечной терапии и на преддиализных стадиях нефропатий. Основное внимание уделяется выбору продуктов с низким соотношением фосфата к белку (Pi/P, мг/г), роли пищевых добавок и лекарственного уменьшения абсорбции фосфата в желудочно-кишечном тракте.
Ключевые слова
гиперфосфатемия,
диета,
хроническая болезнь почек,
hyperphosphatemia,
dietary control,
chronic kidney disease
Об авторах
В. М. Ермоленко
ГБОУ ДПО РМАПО Министерства здравоохранения РФ, г. Москва
Россия
Россия
Н. Н. Филатова
ГБОУ ДПО РМАПО Министерства здравоохранения РФ, г. Москва
Россия
Россия
Список литературы
1. Земченков А.Ю., Герасимчук Р.П., Вишневский К.А., Земченков Г.А. Гиперфосфатемия у пациентов с хронической болезнью почек на диализе: риски и возможности коррекции // Клиническая нефрология. 2013. N 4. С. 13-20.
2. Adeney K.L., Siscovick D.S., Ix J.H. et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD // J Am Soc Nephrol. 2009. Vol. 20. P. 381-387.
3. Altschul R., Hoffer A., Stephen J.D. Influence of nicotinic acid on serum cholesterol in man // Arch Biochem Biophys. 1955. Vol. 54. P. 558-589.
4. Barsotti G., Morelli E., Giannoni A. et al. Restricted phosphorus and nitrogen intake to slow the progression of chronic renal failure: a controlled trial // Kidney Int Suppl. 1983. Vol. 16. P. S278-284.
5. Bell R.R., Draper H.H., Tzeng D.Y. et al. Physiological responses of human adults to foods containing phosphate additives // J Nutr. 1977. Vol. 107. P. 42-50.
6. Block G.A., Klassen P.S., Lazarus J.M. et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis // J Am Soc Nephrol. 2004. Vol. 15. P. 2208-2218.
7. Boaz M., Smetana S. Regression equation predicts dietary phosphorus intake from estimate of dietary protein intake // J Am Diet Assoc. 1996. Vol. 96. P. 1268-1270.
8. Bohn L., Meyer A.S., Rasmussen S.K. Phytate: impact on environment and human nutrition. A challenge for molecular breeding // J Zhejiang Univ Sci B. 2008. Vol. 9. P. 165-191.
9. Calvo M.S., Park Y.K. Changing phosphorus content of the U.S. diet: potential for adverse effects on bone // J Nutr. 1996. Vol. 126 (Suppl 4). P. 1168S-1180S.
10. Cannata-Andía J.B., Fernández-Martín J.L., Locatelli F. et al. Use of phosphate-binding agents is associated with a lower risk of mortality // Kidney Int. 2013. Vol. 84. P. 998-1008.
11. Cheng S.C., Young D.O., Huang Y. et al. A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients // Clin J Am Soc Nephrol. 2008. Vol. 3. P. 1131-1138.
12. Chiu Y.W., Teitelbaum I., Misra M. et al. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients // Clin J Am Soc Nephrol. 2009. Vol. 4. P. 1089-1096.
13. Cozzolino M., Gentile G., Mazzaferro S. et al. Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease: a hypothesis // Am J Kidney Dis. 2013. Vol. 62. P. 984-992.
14. Craver L., Marco M.P., Sarro F. et al. Mineral metabolism influences pulse pressure increase provoked by chronic kidney disease // Clin Nephrol. 2007. Vol. 68. P. 87-92.
15. Dwyer J.P., Sika M., Schulman G. et al. Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial // Am J Kidney Dis. 2013. Vol. 61. P. 759-766.
16. Edalat-Nejad M., Zameni F., Talaiei A. The effect of niacin on serum phosphorus levels in dialysis patients // Indian J Nephrol. 2012. Vol. 22. P. 174-178.
17. Eto N., Miyata Y., Ohno H., Yamashita T. Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure // Nephrol Dial Transplant. 2005. Vol. 20. P. 1378-1384.
18. Fang Y., Ginsberg C., Sugatani T. et al. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification // Kidney Int. 2014. Vol. 85. P. 142-150.
19. Finch J.L., Lee D.H., Liapis H. et al. Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification // Kidney Int. 2013. Vol. 84. P. 1145-1153.
20. Foley R.N. Phosphate levels and cardiovascular disease in the general population // Clin J Am Soc Nephrol. 2009. Vol. 4. P. 1136-1139.
21. Gutzwiller J.P., Schneditz D., Huber A.R. et al. Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose // Nephrol Dial Transplant. 2002. Vol. 17. P. 1037-1044.
22. Hruska K.A., Mathew S., Lund R. et al. Hyperphosphatemia of chronic kidney disease // Kidney Int. 2008. Vol. 74. P. 148-157.
23. Huang X., Jiménez-Moleón J.J., Lindholm B. et al. Mediterranean diet, kidney function, and mortality in men with CKD // Clin J Am Soc Nephrol. 2013. Vol. 8. P. 1548-1555.
24. Ibels L.S., Alfrey A.C., Haut L., Huffer W.E. Preservation of function in experimental renal disease by dietary restriction of phosphate // N Engl J Med. 1978. Vol. 19. P. 122-126.
25. Isakova T., Gutiérrez O.M., Chang Y. et al. Phosphorus binders and survival on hemodialysis // J Am Soc Nephrol. 2009. Vol. 20. P. 388-396.
26. Isakova T., Wahl P., Vargas G.S. et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease // Kidney Int. 2011. Vol. 79. P. 1370-1378.
27. Isakova T., Wolf M.S. FGF23 or PTH: which comes first in CKD? // Kidney Int. 2010. Vol. 78. P. 947-949.
28. Kalantar-Zadeh K., Gutekunst L., Mehrotra R. et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease // Clin J Am Soc Nephrol. 2010. Vol. 5. P. 519-30.
29. Kalantar-Zadeh K., Kuwae N., Regidor D.L. et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients // Kidney Int. 2006. Vol. 70. P. 771-780.
30. Karamanidou C., Clatworthy J., Weinman J., Horne R. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease // BMC Nephrol. 2008. Vol. 9. P. 2.
31. Karp H.J., Vaihia K.P., Kärkkäinen M.U. et al. Acute effects of different phosphorus sources on calcium and bone metabolism in young women: a whole-foods approach // Calcif Tissue Int. 2007. Vol. 80. P. 251-258.
32. Katai K., Tanaka H., Tatsumi S. et al. Nicotinamide inhibits sodium-dependent phosphate co-transport activity in rat small intestine // Nephrol Dial Transplant. 1999. Vol. 14. P. 1195-1201.
33. Kayne L.H., D’Argenio D.Z., Meyer J.H. et al. Analysis of segmental phosphate absorption in intact rats. A compartmental analysis approach // J Clin Invest. 1993. Vol. 91. P. 915-922.
34. Kooienga L. Phosphorus balance with daily dialysis // Semin Dial. 2007. Vol. 20. P. 342-345.
35. Kopple J.D., Massry S.G. Kopple and Massry’s Nutritional Management of Renal Disease // 2nd ed. Philadelphia. PA: Lippincott Williams & Wilkins, 2004.
36. Leon J.B., Sullivan C.M., Sehgal A.R. The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores // J Ren Nutr. 2013. Vol. 23. P. 265-270.
37. Leypoldt J.K., Agar B.U., Akonur A. et al. Determinants of phosphorus mobilization during hemodialysis // Kidney Int. 2013. Vol. 84. P. 841-848.
38. Lynch K.E., Lynch R., Curhan G.C., Brunelli S.M. Prescribed dietary phosphate restriction and survival among hemodialysis patients // Clin J Am Soc Nephrol. 2011. Vol. 6. P. 620-629.
39. Maccubbin D., Tipping D., Kuznetsova O. et al. Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial // Clin J Am Soc Nephrol. 2010. Vol. 5. P. 582-589.
40. Manley H.J., Garvin C.G., Drayer D.K. et al. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider // Nephrol Dial Transplant. 2004. Vol. 19. P. 1842-1848.
41. Mayne T.J., Benner D., Ricketts K. et al. Results of a pilot program to improve phosphorus outcomes in hemodialysis patients // J Ren Nutr. 2012. Vol. 22. P. 472-479.
42. Moe S.M., Zidehsarai M.P., Chambers M.A. et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease // Clin J Am Soc Nephrol. 2011. Vol. 6. P. 257-264.
43. Müller D., Mehling H., Otto B. et al. Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients // Clin J Am Soc Nephrol. 2007. Vol. 2. P. 1249-1254.
44. Murtaugh M.A., Filipowicz R., Baird B.C. et al. Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III // Nephrol Dial Transplant. 2012. Vol. 27. P. 990-996.
45. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease // Am J Kidney Dis. 2003. Vol. 42 (4 Suppl 3). P. S1-201.
46. Naveh-Many T., Bell O., Silver J., Kilav R. Cis and trans acting factors in the regulation of parathyroid hormone (PTH) mRNA stability by calcium and phosphate // FEBS Lett. 2002. Vol. 529. P. 60-64.
47. Noori N., Kalantar-Zadeh K., Kovesdy C.P. et al. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients // Clin J Am Soc Nephrol. 2010. Vol. 5. P. 683-692.
48. Penne E.L., van der Weerd N.C., Grooteman M.P. et al. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients // Clin J Am Soc Nephrol. 2011. Vol. 6. P. 281-289.
49. Piccoli G.B., Ferraresi M., Deagostini M.C. et al. Vegetarian low-protein diets supplemented with keto analogues: a niche for the few or an option for many? // Nephrol Dial Transplant. 2013. Vol. 28. P. 2295-2305.
50. Sampathkumar K. Niacin and analogs for phosphate control in dialysis--perspective from a developing country // Int Urol Nephrol. 2009. Vol. 41. P. 913-918.
51. Sampathkumar K., Selvam M., Sooraj Y.S. et al. Extended release nicotinic acid - a novel oral agent for phosphate control // Int Urol Nephrol. 2006. Vol. 38. P. 171-174.
52. Sampathkumar K., Sooraj Y.S., Ajeshkumar R.P. Extended release nicotinic acid is a promising agent for phosphate control in hemodialysis // Kidney Int. 2006. Vol. 69. P. 1281.
53. Sandberg A.S., Andersson H., Kivistö B., Sandström B. Extrusion cooking of a high-fibre cereal product. 1. Effects on digestibility and absorption of protein, fat, starch, dietary fiber and phytate in the small intestine // Br J Nutr. 1986. Vol. 55. P. 245-254.
54. Schiavi S.C., Tang W., Bracken C. et al. Npt2b deletion attenuates hyperphosphatemia associated with CKD // J Am Soc Nephrol. 2012. Vol. 23. P. 1691-1700.
55. Sherman R.A., Mehta O. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources // Am J Kidney Dis. 2009. Vol. 54. P. 18-23.
56. Shinaberger C.S., Greenland S., Kopple J.D. et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? // Am J Clin Nutr. 2008. Vol. 88. P. 1511-1518.
57. Shinaberger C.S., Kilpatrick R.D., Regidor D.L. et al. Longitudinal associations between dietary protein intake and survival in hemodialysis patients // Am J Kidney Dis. 2006. Vol. 48. P. 37-49.
58. Slatopolsky E., Robson A.M., Elkan I., Bricker N.S. Control of phosphate excretion in uremic man. // J Clin Invest. 1968. Vol. 47. P. 1865-1874.
59. Spalding E.M., Chamney P.W., Farrington K. Phosphate kinetics during hemodialysis: Evidence for biphasic regulation // Kidney Int. 2002. Vol. 61. P. 655-667.
60. Speer T., Zewinger S., Fliser D. Uraemic dyslipidaemia revisited: role of high-density lipoprotein // Nephrol Dial Transplant. 2013. Vol. 28. P. 2456-2463.
61. Sullivan C., Sayre S.S., Leon J.B. et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial // JAMA. 2009. Vol. 301. P. 629-635.
62. Sullivan C.M., Leon J.B., Sehgal A.R. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients // J Ren Nutr. 2007. Vol. 17. P. 350-354.
63. Takahashi Y., Tanaka A., Nakamura T. et al. Nicotinamide suppresses hyperphosphatemia in hemodialysis patients // Kidney Int. 2004. Vol. 65. P. 1099-1104.
64. Taylor L.M., Kalantar-Zadeh K., Markewich T. et al. Dietary egg whites for phosphorus control in maintenance haemodialysis patients: a pilot study // J Ren Care. 2011. Vol. 37. P. 16-24.
65. Tenenhouse H.S. Regulation of phosphorus homeostasis by the type IIa Na/phosphate co-transporter // Annu Rev Nutr. 2005. Vol. 25. P. 197-214.
66. Tentori F., Blayney M.J., Albert J.M. et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS) // Am J Kidney Dis. 2008. Vol. 52. P. 519-530.
67. The USRDS Dialysis Morbidity and Mortality Study: Wave 2. United States Renal Data System // Am J Kidney Dis. 1997. Vol. 30 (2 Suppl 1). P. S67-85.
68. Tomiyama C, Higa A, Dalboni MA et al. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients // Nephrol Dial Transplant. 2006. Vol. 21. P. 2464-2471.
69. Tonelli M., Pannu N., Manns B. Oral phosphate binders in patients with kidney failure // N Engl J Med. 2010. Vol. 362. P. 1312-1324.
70. Tonelli M., Sacks F., Pfeffer M. et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease // Circulation. 2005. Vol. 112. P. 2627-2633.
71. Uribarri J. Phosphorus additives in food and their effect in dialysis patients // Clin J Am Soc Nephrol. 2009. Vol. 4. P. 1290-1292.
72. Wolf M. Forging forward with 10 burning questions on FGF23 in kidney disease // J Am Soc Nephrol. 2010. Vol. 21. P. 1427-1435.
73. Wüthrich R.P., Chonchol M., Covic A. et al. Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients // Clin J Am Soc Nephrol. 2013. Vol. 8. P. 280-289.
74. Young D.O., Cheng S.C., Delmez J.A., Coyne D.W. The effect of oral niacinamide on plasma phosphorus levels in peritoneal dialysis patients // Perit Dial Int. 2009. Vol. 29. P. 562-567.
75. Zoccali C., Ruggenenti P., Perna A. et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition // J Am Soc Nephrol. 2011. Vol. 22. P. 1923-1930.
Рецензия
Для цитирования:
Ермоленко В.М., Филатова Н.Н. Возможности диетического контроля гиперфосфатемии при ХБП (Обзор литературы). Нефрология и диализ. 2014;16(2):228-235.
For citation:
Ermolenko V.M., Filatova N.N. Possibility of dietary control of hyperphosphatemia in CKD Review. Nephrology and Dialysis. 2014;16(2):228-235. (In Russ.)
Просмотров:
30
Послать статью по эл. почте 